文献速递神经肿瘤

复发性颅底脑膜瘤再次手术后的手术结局

Surgical outcomes after reoperation for recurrent skull base meningiomas.
PubMed 文献 · J Neurosurg · 2018-05-04

该回顾性研究分析了1985至2016年间2120例脑膜瘤切除术患者中78例因复发性颅底脑膜瘤接受100次再次手术的病例。再次手术并发症发生率高(100次手术中30例出现60次并发症),后颅窝位置与并发症显著相关(OR 3.45,p=0.0472)。尽管并发症风险高,适当选择患者的重复切除仍提供良好的长期生存(首次再次手术后中位生存17年)。

要点

  • 复发性颅底脑膜瘤再次手术与高并发症率相关,100次手术中30例发生60次并发症。
  • 后颅窝位置是并发症的显著危险因素(OR 3.45,p=0.0472)。
  • 首次再次手术后1、2、5、10年总生存率分别为94%、92%、88%、76%,中位生存17年。

核心结论

  • 复发性颅底脑膜瘤是手术具有挑战性的肿瘤,再次手术与高发病率及并发症率相关。
  • 尽管有这些警示性数据,在适当选择的患者中重复切除复发性颅底脑膜瘤可提供极好的长期生存。

研究设计与样本

  • 回顾性综述1985年至2016年间2120例接受脑膜瘤切除术的患者。
  • 从医疗记录、影像学数据和病理学数据中提取临床信息。
  • 回顾所有复发性颅底脑膜瘤患者的记录,收集人口学数据、就诊症状、手术管理、结局和并发症数据。
  • 采用Kaplan-Meier分析评估再次手术后的生存,采用逻辑回归评估与并发症相关的危险因素。

主要发现

  • 78例患者因复发性颅底脑膜瘤接受了100次再次手术;17例有2次再次手术,3例有3次,2例有4次或以上。
  • 诊断时中位年龄52岁,64%为女性,中位随访8.5年;从初次切除到首次再次手术的中位时间为4.4年,从首次到第二次再次手术为4.1年。
  • 72%的肿瘤为WHO I级,22%为WHO II级,6%为WHO III级;蝶骨翼是最常见位置(31%),其次为桥小脑角(14%)、海绵窦(13%)、嗅沟(12%)、鞍结节(12%)和中颅窝底(5%)。
  • 首次再次手术时44例(54%)肿瘤最大直径≥3 cm;100次再次手术中,30例发生60次并发症,其中20次(33%)需要手术干预。
  • 并发症包括脑积水(12)、脑脊液漏/假性脑膜膨出(11)、伤口感染(9)、术后血肿(4)、静脉梗死(1)和气颅(1);术后神经功能缺损包括新发或加重的颅神经缺损(10)和偏瘫(3);本组无围手术期死亡。

临床怎么用

  • 作者认为,尽管再次手术与高并发症率相关,在适当选择的患者中重复切除复发性颅底脑膜瘤可提供极好的长期生存。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Skull base meningiomas are surgically challenging tumors due to the intricate skull base anatomy and the proximity of cranial nerves and critical cerebral vasculature. Many studies have reported outcomes after primary resection of skull base meningiomas; however, little is known about outcomes after reoperation for recurrent skull base meningiomas. Since reoperation is one treatment option for patients with recurrent meningioma, the authors sought to define the risk profile for reoperation of skull base meningiomas. METHODS: A retrospective review of 2120 patients who underwent resection of meningiomas between 1985 and 2016 was conducted. Clinical information was extracted from the medical records, radiology data, and pathology data. All records of patients with recurrent skull base meningiomas were reviewed. Demographic data, presenting symptoms, surgical management, outcomes, and complications data were collected. Kaplan-Meier analysis was used to evaluate survival after reoperation. Logistic regression was used to evaluate for risk factors associated with complications. RESULTS: Seventy-eight patients underwent 100 reoperations for recurrent skull base meningiomas. Seventeen patients had 2 reoperations, 3 had 3 reoperations, and 2 had 4 or more reoperations. The median age at diagnosis was 52 years, and 64% of patients were female. The median follow-up was 8.5 years. Presenting symptoms included cranial neuropathy, headache, seizure, proptosis, and weakness. The median time from initial resection to first reoperation was 4.4 years and 4.1 years from first to second reoperation. Seventy-two percent of tumors were WHO grade I, 22% were WHO grade II, and 6% were WHO grade III. The sphenoid wing was the most common location (31%), followed by cerebellopontine angle (14%), cavernous sinus (13%), olfactory groove (12%), tuberculum sellae (12%), and middle fossa floor (5%). Forty-four (54%) tumors were ≥ 3 cm in maximum diameter at the time of the first reoperation. In 100 reoperations, 60 complications occurred in 30 cases. Twenty of the 60 complications required surgical intervention (33%). Complications included hydrocephalus (12), CSF leak/pseudomeningocele (11), wound infection (9), postoperative hematoma (4), venous infarction (1), and pneumocephalus (1). Postoperative neurological deficits included new or worsened cranial nerve deficits (10) and hemiparesis (3). There were no perioperative deaths in this series. On multivariate analysis, posterior fossa location was significantly associated with complications (OR 3.45, p = 0.0472). The 1-, 2-, 5-, and 10-year overall survival rates according to Kaplan-Meier analysis after the first reoperation were 94%, 92%, 88%, and 76%, respectively. The median survival after the first reoperation was 17 years. CONCLUSIONS: Recurrent skull base meningiomas are surgically challenging tumors, and reoperation is associated with high morbidity and complication rates. Despite these cautionary data, repeat resection of recurrent skull base meningiomas in appropriately selected patients provides excellent long-term survival.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Magill ST, Lee DS, Yen AJ, et al. Surgical outcomes after reoperation for recurrent skull base meningiomas. J Neurosurg. 2018. PMID: 29726777. doi:10.3171/2017.11.JNS172278

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。